Circulating angiogenic factors in singleton vs multiple-gestation pregnancies

Am J Obstet Gynecol. 2008 Feb;198(2):200.e1-7. doi: 10.1016/j.ajog.2007.08.042.

Abstract

Objective: Placental soluble fms-like tyrosine kinase-1 may contribute to the pathogenesis of preeclampsia. Here we describe alterations in serum angiogenic factor levels in women with multiple gestation pregnancies, a major preeclampsia risk factor.

Study design: We collected serial serum specimens from 101 pregnant women at high preeclampsia risk between 22 and 36 weeks' gestation. Soluble fms-like tyrosine kinase-1 and placental growth factor were measured by enzyme-linked immunosorbent assay. Women who had preeclampsia or gestational hypertension develop were excluded.

Results: Maternal soluble fms-like tyrosine kinase-1 was higher in multiple gestation (n = 20) compared with high-risk singleton (n = 81) pregnancies for each gestational age range examined. Maternal placental growth factor was significantly higher in multiple vs high-risk singletons before 31 weeks' gestation, whereas the soluble fms-like tyrosine kinase-1/placental growth factor ratio was higher in multiple vs high-risk singletons after 27 weeks.

Conclusion: Alterations in circulating angiogenic factors are present in women with multiple gestations and may contribute to higher preeclampsia risk in this population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angiogenic Proteins / blood*
  • Case-Control Studies
  • Cohort Studies
  • Female
  • Gestational Age
  • Humans
  • Placenta Growth Factor
  • Pre-Eclampsia / blood*
  • Pregnancy
  • Pregnancy Proteins / blood*
  • Pregnancy Trimester, Third
  • Pregnancy, High-Risk / blood
  • Pregnancy, Multiple / blood*
  • Vascular Endothelial Growth Factor Receptor-1 / blood*

Substances

  • Angiogenic Proteins
  • PGF protein, human
  • Pregnancy Proteins
  • Placenta Growth Factor
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1